Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent M Humeau

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Enhanced Delivery of DNA or RNA Vaccines by ElectroporationKate E Broderick, Laurent M Humeau
Expert Review of Vaccines|December 10, 2014
Electroporation-enhanced delivery of nucleic acid vaccinesKate E Broderick, Laurent M Humeau
Current Opinion in Molecular Therapeutics|October 7, 2009
Lentiviral vectors in clinical trials: Current statusJenice D'Costa, S Gary Mansfield, Laurent M Humeau
Journal of Virology|June 5, 2009
The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4+ T cells than the vesicular stomatitis virus glycoprotein G envelopeLuis M Agosto, Jianqing J Yu, Megan K Liszewski, et al.
Plos One|November 3, 2010
Development of a low bias method for characterizing viral populations using next generation sequencing technologyStephanie M Willerth, Hélder A M Pedro, Lior Pachter, et al.
Journal of Virology|September 5, 2008
Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alphaMax W Richardson, Richard G Carroll, Matthew Stremlau, et al.
Human Vaccines & Immunotherapeutics|May 10, 2019
Immunogenicity of a protective intradermal DNA vaccine against lassa virus in cynomolgus macaquesJingjing Jiang, Preeti Banglore, Kathleen A Cashman, et al.
Human Gene Therapy|June 30, 2007
Potent inhibition of simian immunodeficiency virus (SIV) replication by an SIV-based lentiviral vector expressing antisense EnvStephen E Braun, Xiaobin V Lu, Fay Eng Wong, et al.
Human Gene Therapy|February 11, 2005
Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vectorPeter Manilla, Tessio Rebello, Cathleen Afable, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral loadLaurent M Humeau, Gwendolyn K Binder, Xiaobin Lu, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Enhanced Delivery of DNA or RNA Vaccines by ElectroporationKate E Broderick, Laurent M Humeau
Expert Review of Vaccines|December 10, 2014
Electroporation-enhanced delivery of nucleic acid vaccinesKate E Broderick, Laurent M Humeau
Current Opinion in Molecular Therapeutics|October 7, 2009
Lentiviral vectors in clinical trials: Current statusJenice D'Costa, S Gary Mansfield, Laurent M Humeau
Journal of Virology|June 5, 2009
The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4+ T cells than the vesicular stomatitis virus glycoprotein G envelopeLuis M Agosto, Jianqing J Yu, Megan K Liszewski, et al.
Plos One|November 3, 2010
Development of a low bias method for characterizing viral populations using next generation sequencing technologyStephanie M Willerth, Hélder A M Pedro, Lior Pachter, et al.
Journal of Virology|September 5, 2008
Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alphaMax W Richardson, Richard G Carroll, Matthew Stremlau, et al.
Human Vaccines & Immunotherapeutics|May 10, 2019
Immunogenicity of a protective intradermal DNA vaccine against lassa virus in cynomolgus macaquesJingjing Jiang, Preeti Banglore, Kathleen A Cashman, et al.
Human Gene Therapy|June 30, 2007
Potent inhibition of simian immunodeficiency virus (SIV) replication by an SIV-based lentiviral vector expressing antisense EnvStephen E Braun, Xiaobin V Lu, Fay Eng Wong, et al.
Human Gene Therapy|February 11, 2005
Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vectorPeter Manilla, Tessio Rebello, Cathleen Afable, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral loadLaurent M Humeau, Gwendolyn K Binder, Xiaobin Lu, et al.
Pageof 4